Articles by Katie Anderson
-
AI In Action: Evaluating Project Assessment
11/9/2026
In this four-part series of interviews at ISPE’s Annual Meeting & Expo, I talk to experts who have made advances in AI, all in different areas, to do their job more efficiently. We explore project assessment here, but will also explore cleaning validation, continuous verification and risk assessment in future segments.
-
Modulus Brings Home Top Award At 2026 FOYAs
10/31/2026
The ingenuity on display went well beyond the latest equipment. From technological innovation and operational excellence to sustainability and supply chain solutions, the FOYAs celebrated how facility design brings these pieces together to create a superior working environment.
-
Designing Pharma Facilities For Change, Not Just Capacity
10/28/2026
Pharmaceutical innovation is making drug manufacturing more complex—and placing new demands on facility design. Accommodating today’s processes is no longer enough. Facilities must also be able to change. Modular design offers a way to build that adaptability into the facility itself.
-
Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up
10/26/2026
For oral solid dose (OSD) manufacturers, technology transfer often becomes an exercise in managing uncertainty. Differences in equipment, blending conditions, material properties, and tooling design can introduce challenges that may not become apparent until later-stage development or even commercial scale-up.
-
Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
10/19/2026
Though methotrexate is the most effective therapeutic against primary central nervous system (CNS) lymphoma, it can cause toxicity issues at therapeutic concentrations. Aditi Suchitkumar Satoskar and her research team at Mercer University sought to look for alternatives, investigating a noninvasive approach that combines methotrexate-loaded bovine serum albumin nanoparticles, an RVG-derived brain-targeting peptide, and a 3D-printed buccal film.
-
Capturing Tablet Disintegration for Improved OSD Development
10/15/2026
Closed-loop laboratory automation promises to make oral solid dosage form development faster and more efficient, but the behavior of powders, tablets and dissolution processes remains difficult to predict.
-
Why CMC Tech Transfer Should Begin With The End In Mind
10/1/2026
This interview with Sai Life Sciences’ Tuneer Ghosh explains why CMC technology transfer should begin with commercialization and lifecycle goals in mind. It highlights how early planning for scale, CDMO involvement, supply resilience, regulatory requirements, process safety, and shared learning can support a smoother, more sustainable transfer.
-
4 Ways To Build A Better CMC Tech Transfer
9/23/2026
A technology transfer can falter long before a process reaches the plant. Gaps in process knowledge, mismatched equipment, and insufficient scale-up data can all undermine reproducibility, timelines, and cost.
-
AI Governance Is Just Like Driving A Race Car
9/1/2026
Though some skeptics remain, nearly every business is at some stage of AI adoption. The technology has proven applications in pharmaceutical manufacturing, but effective governance must keep pace with its rapid development. That challenge is familiar to Bill Reid, healthcare and life sciences lead in Google’s Chief Information Security Office (CISO).
-
Can U.S. Policy Bring Generic Drug Manufacturing Back Home?
8/25/2026
Generic medicines imported into the U.S. were not subject to the recently imposed tariffs on imported pharmaceuticals, but President Trump posted in July that this could change within two years.